VECT — VectivBio Holding AG Share News
0.000.00%
HealthcareAdventurousMid Cap
Brief: Ironwood Pharmaceuticals Says If Deal Aborts, VectivBio To Pay Termination Fee
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill
U.S. STOCKS ON THE MOVE-Hepion Pharma, AVROBIO, Volcon
VectivBio surges as Ironwood Pharma to buy co for $1.15 bln
Ironwood Pharma to acquire VectivBio for $1.15 bln (updated)
Ironwood Pharma to acquire Swiss-based VectivBio in $1 bln deal
Brief: Vectivbio Reports Full Year 2022 Financial Results And Provides Business Update
Swiss stocks - Factors to watch on April 19
VectivBio Holding AG expected to post a loss of 56 cents a share - Earnings Preview
Brief: Vectivbio And Asahi Kasei Pharma Announce The Start Of A Phase 1 Study Of Apraglutide In Japan
Brief: Vectivbio Holding AG Files For Mixed Shelf Of Up To $350 Million
Brief: Vectivbio Announces Completion Of Enrollment For Colon-In-Continuity Cohort Of Stars Pivotal Phase 3 Study Investigating Apraglutide In Short Bowel Syndrome With Intestinal Failure
U.S. STOCKS ON THE MOVE-BeiGene, Avient, Reata
U.S. STOCKS ON THE MOVE-Netflix, BeiGene, Norfolk
Corrected: BUZZ-VectivBio slips after stock offering
VectivBio jumps on promising mid-stage data for bowel disorder drug
VectivBio gains on promising mid-stage data for bowel disorder drug